CN Patent

CN1950090A — 美洛昔康制剂在兽医学中的应用

Assigned to Boehringer Ingelheim Vetmedica GmbH · Expires 2007-04-18 · 19y expired

What this patent protects

本发明涉及含有美洛昔康或美洛昔康的可药用有机或无机碱盐、一种或多种载体以及一种或多种适宜添加剂的制剂在制备用于乳房内治疗哺乳动物炎性疾病、特别是乳腺炎的兽用药物组合物中的用途。所述乳房内给药方式可以在靶组织中获得有效浓度，从而迅速发挥作用。

USPTO Abstract

本发明涉及含有美洛昔康或美洛昔康的可药用有机或无机碱盐、一种或多种载体以及一种或多种适宜添加剂的制剂在制备用于乳房内治疗哺乳动物炎性疾病、特别是乳腺炎的兽用药物组合物中的用途。所述乳房内给药方式可以在靶组织中获得有效浓度，从而迅速发挥作用。

Drugs covered by this patent

Patent Metadata

Patent number
CN1950090A
Jurisdiction
CN
Classification
—
Expires
2007-04-18
Drug substance claim
No
Drug product claim
No
Assignee
Boehringer Ingelheim Vetmedica GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.